Funding · Company
Delfi Diagnostics, Inc.
Baltimore, MDBiotech & Pharma
Delfi Diagnostics, Inc. of Baltimore, MD has disclosed $259M across 2 Form D offerings filed with the SEC between Jul 25, 2022 and Dec 18, 2025.
$259M
Total disclosed
2
Form D offerings
2018
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$34M
Form D · Dec 18, 2025 ↗
Q4 2025
· target $60M
Filing details
HeadquartersBaltimore, MDIndustryBiotech & Pharma (Biotechnology)Incorporated2018SEC CIK0001783735Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →